Lanreotide diTFA

• Target:

  Somatostatin

• Related Pathways:

  GPCR/G Protein

• Bioactivity:

  Lanreotide (BIM 23014) diTFA, a somatostatin analogue, exhibits antineoplastic activity and may be utilized in carcinoid syndrome research [1] [2].

• Smiles:

  OC(C(F)(F)F)=O.O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)C(N[C@H](C(N)=O)[C@H](O)C)=O)NC([C@H](N)CC2=CC3=C(C=CC=C3)C=C2)=O)=O)CC4=CC=C(C=C4)O)N[C@@H]1CC5=CNC6=CC=CC=C56.OC(C(F)(F)F)=O

• Molecular Formula:

  C58H71F6N11O14S2

• Molecular Weight:

  1324.37

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1024499-83-9